SCHEMBL2863181

SCHEMBL2863181

Fc1cc2[nH]nc(-c3cc4ccccc4s3)c2cc1Br

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPKAPK2 P49137 1/20 0.48
MAPK10 P53779 1/20 0.43
ITK Q08881 5/20 0.39
SIRT2 Q8IXJ6 1/20 0.38
SIRT1 Q96EB6 1/20 0.38
PIK3R1 P27986 1/20 0.37
PIK3CA P42336 1/20 0.37
DYRK1A Q13627 2/20 0.36
MAP2K4 P45985 1/20 0.36
DCLK1 O15075 1/20 0.36
PRKD3 O94806 1/20 0.36
MAP4K4 O95819 1/20 0.36
CHEK2 O96017 1/20 0.36
CSF1R P07333 1/20 0.36
FER P16591 1/20 0.36
CDK2 P24941 1/20 0.36
MARK3 P27448 1/20 0.36
FLT4 P35916 1/20 0.36
FLT3 P36888 1/20 0.36
MAPK9 P45984 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2861529 0.85 MAPKAPK2 (0.53) MAPKAPK2MAPK10ITKSIRT2SIRT1
SCHEMBL2870292 0.82 MAPKAPK2 (0.48) MAPKAPK2MAPK10ITKSIRT2SIRT1
SCHEMBL2859875 0.82 MAPKAPK2 (0.46) MAPKAPK2MAPK10ITKSIRT2SIRT1
SCHEMBL2862999 0.81 MAPK10 (0.47) MAPKAPK2MAPK10SIRT2SIRT1MAP2K4
SCHEMBL2866652 0.78 TNIK (0.47) MAPKAPK2MAPK10ITKSIRT2SIRT1
SCHEMBL2862092 0.78 MAPK10 (0.49) MAPKAPK2MAPK10ITKSIRT2SIRT1
SCHEMBL2864582 0.76 CDK2 (0.47) MAPKAPK2MAPK10ITKDYRK1AMAP2K4
SCHEMBL4063951 0.75 ITK (0.42) MAPKAPK2MAPK10ITKSIRT2SIRT1
SCHEMBL2862938 0.74 MAPK10 (0.50) MAPKAPK2MAPK10SIRT2SIRT1DYRK1A
SCHEMBL4329381 0.74 MAPK10 (0.59) MAPKAPK2MAPK10ITKSIRT2SIRT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7776890-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-17 US disclosed
EP-1380576-B1 1H-INDAZOLE COMPOUNDS INHIBITING JNK EISAI R&D MAN CO LTD (JP) 2009-11-25 EP disclosed
US-20090203691-A1 Novel 1H-indazole compounds OINUMA HITOSHI 2009-08-13 US disclosed
US-7541376-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-02 US disclosed
US-6982274-B2 1H-indazole compound EISAI CO., LTD. (JP) 2006-01-03 US disclosed
US-20050282880-A1 Novel 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2005-12-22 US disclosed
US-20040127538-A1 Novel 1h-indazole compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2004-07-01 US disclosed
EP-1380576-A1 NOVEL 1H-INDAZOLE COMPOUND Eisai Co., Ltd. (JP) 2004-01-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203691-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 MAPKAPK2 18/4885MAPK10 29/4885ITK 3726/4885
US-20040127538-A1 Novel 1h-indazole compound MAPK1, MAPK14, MAPK3 MAPKAPK2 26/4885MAPK10 27/4885ITK 3628/4885
US-20050282880-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 MAPKAPK2 18/4885MAPK10 29/4885ITK 3726/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.